BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2910909)

  • 1. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the anticoagulant activity of protein S by prothrombin.
    Mitchell CA; Jane SM; Salem HH
    J Clin Invest; 1988 Dec; 82(6):2142-7. PubMed ID: 2974048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.
    Hoekema L; Nicolaes GA; Hemker HC; Tans G; Rosing J
    Biochemistry; 1997 Mar; 36(11):3331-5. PubMed ID: 9116011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L; He X; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticoagulant properties of a modified form of protein S.
    Mitchell CA; Kelemen SM; Salem HH
    Thromb Haemost; 1988 Oct; 60(2):298-304. PubMed ID: 2975408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiolipin enhances protein C pathway anticoagulant activity.
    Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
    Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin.
    Béguin S; Lindhout T; Hemker HC
    Thromb Haemost; 1989 Feb; 61(1):25-9. PubMed ID: 2749591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.
    Magdeleyns EJ; Keuren JF; Curvers J
    Transfusion; 2007 Oct; 47(10):1880-8. PubMed ID: 17880615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
    Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.